- Home
- FULC vs CRNC Comparison
FULC vs CRNC Comparison
Compare FULC & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- CRNC
- Stock Information
- Founded
- FULC 2015
- CRNC 2020
- Country
- FULC United States
- CRNC United States
- Employees
- FULC N/A
- CRNC N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- CRNC EDP Services
- Sector
- FULC Health Care
- CRNC Technology
- Exchange
- FULC Nasdaq
- CRNC Nasdaq
- Market Cap
- FULC 375.4M
- CRNC 403.2M
- IPO Year
- FULC 2019
- CRNC N/A
- Fundamental
- Price
- FULC $6.45
- CRNC $9.37
- Analyst Decision
- FULC Buy
- CRNC Buy
- Analyst Count
- FULC 8
- CRNC 6
- Target Price
- FULC $7.13
- CRNC $10.17
- AVG Volume (30 Days)
- FULC 984.6K
- CRNC 1.7M
- Earning Date
- FULC 07-29-2025
- CRNC 08-06-2025
- Dividend Yield
- FULC N/A
- CRNC N/A
- EPS Growth
- FULC N/A
- CRNC N/A
- EPS
- FULC N/A
- CRNC N/A
- Revenue
- FULC N/A
- CRNC $245,947,000.00
- Revenue This Year
- FULC N/A
- CRNC N/A
- Revenue Next Year
- FULC N/A
- CRNC $7.31
- P/E Ratio
- FULC N/A
- CRNC N/A
- Revenue Growth
- FULC 2752.05
- CRNC N/A
- 52 Week Low
- FULC $2.32
- CRNC $2.36
- 52 Week High
- FULC $10.13
- CRNC $27.50
- Technical
- Relative Strength Index (RSI)
- FULC 39.24
- CRNC 56.53
- Support Level
- FULC $6.47
- CRNC $8.72
- Resistance Level
- FULC $7.00
- CRNC $9.98
- Average True Range (ATR)
- FULC 0.57
- CRNC 0.52
- MACD
- FULC -0.12
- CRNC 0.06
- Stochastic Oscillator
- FULC 5.42
- CRNC 81.68
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.